MUHC research news
Elderly women with irregular heartbeat at higher risk for stroke
According to a new study led by the Research Institute of the McGill University Health Centre (RI MUHC), older women who have been diagnosed with an irregular heartbeat are at higher risk of stroke than men.
How accurate are rapid flu tests?
A new study conducted by researchers from McGill University, the Research Institute of the McGill University Health Centre (RI MUHC), and Sainte-Justine University Hospital Research Centre, has put the accuracy of rapid influenza diagnostic tests (RIDTs) under the microscope. The meta-analysis of 159 studies showed three key findings.
Neuron memory key to taming chronic pain
A team of researchers led by McGill neuroscientist Terence Coderre, who is also affiliated with the Research Institute of the McGill University Health Centre, has found the key to understanding how memories of pain are stored in the brain. More importantly, the researchers are also able to suggest how these memories can be erased, making it possible to ease chronic pain.
Genetic breakthrough for brain cancer in children
Canadian-led research team identifies two mutations in crucial gene involved in deadly pediatric brain tumours
Saliva HIV test passes the grade
RI-MUHC-led study compares saliva self-test to blood test
Gene acts as a brake on breast cancer progression
New research out of McGill University’s Goodman Cancer Research Centre provides compelling new evidence that a gene known as 14-3-3σ plays a critical role in halting breast cancer initiation and progression. The study, led by the Dept. of Biochemistry’s William J. Muller, will be published online today in the journal Cancer Discovery.
New target identified to stop the spread of breast cancer
A new potential target to slow breast cancer tumor progression and metastasis has been identified by a team of researchers led by Dr. Richard Kremer from the Research Institute of the McGill University Health Centre (RI-MUHC).
Adolescent amphetamine use linked to permanent changes in brain function and behaviour
Amphetamine use in adolescence can cause neurobiological imbalances and increase risk-taking behaviour, and these effects can persist into adulthood, even when subjects are drug free.
Depression treatment combined with heart attack medication - risk of bleeding increases
Patients taking medication to prevent heart attack as well as anti-depressants have a higher risk of developing internal bleeding, according to a new study conducted by researchers at the McGill University Health Centre (MUHC). The results were published this week in the Canadian Medical Association Journal.
Rémillard family establishes the Yosh Taguchi Chair in Urology
McGill University’s Division of Urology has a long history of excellence in patient care, pioneering urologic innovation, fundamental research and education. The Division’s legacy, thanks to the generosity of Lucien Rémillard and his family, has been strengthened.
Research on TB tests prompts first-ever WHO negative policy
McGill / RI MUHC-led teams publish on inaccuracy and poor cost-effectiveness of widely used TB antibody tests
Creative ideas to tackle disease, child labour among innovative projects rewarded
Creative ideas to tackle disease, child labour among innovative projects rewarded
Parasitic worms: A hidden global health threat
MUHC/McGill parasite disease researcher wins International Public Health Award.
Research Institute of the MUHC awarded $1.4M grant for Innovative Medicine
The Research Institute of the McGill University Health Centre (RI-MUHC) was one of three winners in the Fonds de la recherche en santé du Québec (FRSQ) competition 2011-2012. The RI-MUHC won in the category of Projects for innovative strategic development aimed at supporting projects essential to maintaining the competitiveness of a research centre.
Enlarged prostate: decade-long study demonstrates immediate and long-term benefits of holmium laser treatment
New research presented at the Annual Meeting of the American Urology Association (AUA) in Washington, DC demonstrates that holmium laser therapy is a safe and durable treatment option for Benign Prostatic Hyperplasia (BPH) – an enlargement of the prostate that affects most men as they age.
